Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,408 | -13,382 | -20,000 | -9,914 | -9,616 |
| Depreciation Amortization | 291 | 240 | 207 | 149 | 132 |
| Accounts receivable | -232 | -4 | 83 | 49 | 73 |
| Other Working Capital | 995 | -1,124 | 3,757 | 1,959 | 1,239 |
| Other Operating Activity | 12,583 | 4,646 | 6,385 | 4,148 | 1,966 |
| Operating Cash Flow | $-17,771 | $-9,624 | $-9,568 | $-3,609 | $-6,206 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 35,901 | 35,901 | -36,001 | N/A | N/A |
| PPE Investments | -204 | -72 | -271 | -118 | -98 |
| Other Investing Activity | -51 | 0 | -5 | -105 | -5 |
| Investing Cash Flow | $35,646 | $35,829 | $-36,277 | $-223 | $-103 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64,235 | 64,256 | 61,245 | 61,259 | 61,658 |
| Other Financing Activity | 0 | 0 | 340 | 382 | 382 |
| Financing Cash Flow | $64,235 | $64,256 | $61,585 | $61,641 | $62,040 |
| Beginning Cash Position | 36,999 | 36,999 | 21,457 | 21,362 | 21,362 |
| End Cash Position | 119,109 | 127,460 | 37,197 | 79,171 | 77,093 |
| Net Cash Flow | $82,110 | $90,461 | $15,740 | $57,809 | $55,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,771 | -9,624 | -9,568 | -3,609 | -6,206 |
| Capital Expenditure | -204 | -72 | -271 | -118 | -98 |
| Free Cash Flow | -17,975 | -9,696 | -9,839 | -3,727 | -6,304 |